PFE Pfizer
- 28.085
- +0.235+0.84%
Pfizer News
Viagra Maker Viatris Misses Revenue Estimates on Weak Demand for Older Drugs
HLS Therapeutics Faces Q1 Challenges, Ends Pfizer Deal
Moderna's MRNA Dreams Meet Reality With First Post-Covid Shot
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Tesla CEO Elon Musk does not seem to agree with Republicans at least on one thing. On Wednesday, the billionaire, true to his credentials as a tech pioneer, unequivocally backed the mRNA technology, w
Prestige Consumer Healthcare Inc.: John Kelly, Formerly With Pfizer, Elected to Bd. >PBH
Prestige Consumer Healthcare Inc.: John Kelly, Formerly With Pfizer, Elected to Bd. >PBH
Overnight news: European stock market hits record high, US prosecution launches investigation into Tesla's alleged fraud ECB Governing Council says inflation prospects are still at risk
For more global financial information, please follow the 7×24 hour real-time financial news market closing: the rise and fall of the US stock market did not mean that the rise or fall of the US stock market was rising for the 6th day in a row on May 8: Rumor has it that Tesla FSD's suspected fraud was being investigated by the US prosecution. On Wednesday, popular Chinese securities rose 1.1%, while Liwei Xiaopu fell, and US crude oil futures closed 0.8% higher on Wednesday, and European stock market earnings were supported by falling inventory data: the UK FTSE 100 Index and the European STOXX 600 Index all reached record highs, and the European STOXX 600 Index both reached record highs, and the European STOXX 600 Index both reached record highs, and the European STOXX 600 Index all hit record highs in the macro European stock market New high Strong boost in corporate earnings
External market headlines: US money market funds prepare for new regulations Google faces lawsuit in the UK Federal Reserve Governor believes private equity credit has not harmed financial resilience
The main headlines that global financial media paid attention to last night and this morning were: US money market funds are preparing for new regulations; government debt instruments are expected to receive more demand. Money market funds are beginning to adjust their assets in the $6 trillion US money market because a series of new regulations are about to be implemented, which may increase demand for government securities, and demand for riskier assets will be adversely affected. As of mid-April, about five such funds — including the two largest — have announced plans to switch to holding only government securities, or simply shut down to avoid the Securities and Exchange Commission (SEC) this year
Pfizer Options Spot-On: On May 8th, 1.29 Million Contracts Were Traded, With 3.34 Million Open Interest
On May 8th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 1.29 million options for the day, of which put options accounted for 3.16% of the total transactions, and cal
Pfizer | 10-Q: Quarterly report
Express News | Pfizer Inc -Expect Costs Associated With Multi-Year Cost Realignment Effort to Continue Through 2024 and to Total About $2.8 Bln
Express News | NYSE Order Imbalance 71993.0 Shares on Buy Side
Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac
Pfizer Inc (NYSE:PFE) has reportedly settled 10,000 lawsuits alleging it concealed the cancer risks associated with its Zantac heartburn medication, marking the largest resolution in the litigation. T
Sector Update: Health Care Stocks Slipping Wednesday Afternoon
Health care stocks were declining Wednesday afternoon, with the NYSE Health Care Index down 0.4% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.3%. The iShares Biotechnology ETF (IBB)
Pfizer Agrees to Settle 10,000 Zantac Lawsuits Over Alleged Cancer Risks, Bloomberg Reports
-- Pfizer has agreed to settle over 10,000 cases against its heartburn drug Zantac for allegedly hiding cancer-associated risks, Bloomberg reports, citing people familiar with the deal. -- The agreem
Pfizer to Settle Over 10,000 Zantac-related Cancer Claims: Report
UPDATE 1-Pfizer Agrees to Settle Over 10,000 Zantac Lawsuits, Bloomberg News Reports
Pfizer Agrees to Settle More Than 10,000 Zantac Cancer Lawsuits
Street Color: Pfizer Reportedly Agrees to Settle Over 10,000 Zantac Cancer Lawsuits
(Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is
AstraZeneca (AZN.US) withdraws COVID-19 vaccine from the market, emphasizing insufficient demand rather than safety factors
The Zhitong Finance App learned that British pharmaceutical giant AstraZeneca (AZN.US) removed its COVID-19 vaccine from the market, which was once popular all over the world, mainly because the market's demand for this vaccine was insufficient, and initially people hoped that it would play a key role in protecting the world from the virus. AstraZeneca said in a statement that at the company's request, the marketing license for the vaccine Vaxzevria in the EU was withdrawn this week because the vaccine is no longer being produced or supplied. The company said the decision was unrelated to any security reasons. AstraZeneca's COVID-19 vaccine and the University of Oxford
AstraZeneca Is Withdrawing COVID Shot Worldwide Due to Vaccine Glut
Analysis
Price Target
No Data
